Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-16

FDA Approved: FLUCONAZOLE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for Fluconazole from Zydus Lifesciences Limited, resulting in regulatory approval of this generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)